<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04072978</url>
  </required_header>
  <id_info>
    <org_study_id>00046460</org_study_id>
    <nct_id>NCT04072978</nct_id>
  </id_info>
  <brief_title>Anterior Chamber Versus Scleral Fixated Intraocular Lens: Long-term Vision and Safety Outcomes</brief_title>
  <official_title>Anterior Chamber Versus Scleral Fixated Intraocular Lens: Long-term Vision and Safety Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective comparative non-randomized cohort study to understand the long-term
      vision outcomes, safety, and stability of anterior chamber intraocular lenses (AC IOLs) vs.
      scleral-fixated intraocular lenses (SF IOLs).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial cell loss</measure>
    <time_frame>Pre-operative (baseline) and 24 weeks post-operatively.</time_frame>
    <description>Change in endothelial cell count from baseline compared to 24 months post-operatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Corrected distance visual acuity (CDVA)</measure>
    <time_frame>Pre-operative (baseline), week 1, months 1, 6, 12 and 24 post-operatively.</time_frame>
    <description>CDVA will be measured using a standardized Early Treatment Diabetic Retinopathy Study (ETDRS) chart</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Secondary adverse events (SAE's)</measure>
    <time_frame>Pre-operative (baseline), week 1, months 1, 6, 12 and 24 post-operatively.</time_frame>
    <description>Occurrence of cystoid macular edema (CME), retinal detachment, UGH syndrome, vitreous or choroidal hemorrhage, lens subluxation/ dislocation, glaucoma, uveitis, etc.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Corneal Endothelial Cell Loss</condition>
  <condition>Secondary Intraocular Lens</condition>
  <arm_group>
    <arm_group_label>Intraocular lens implantation: AC IOL</arm_group_label>
    <description>Patients who are scheduled to undergo AC IOL (anterior chamber intraocular lens) implantation for any of the following indications:
primary or secondary aphakia
primary or secondary lens subluxation or dislocation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intraocular lens implantation: SF IOL</arm_group_label>
    <description>Patients who are scheduled to undergo SF IOL (scleral fixated intraocular lens) implantation for any of the following indications:
primary or secondary aphakia
primary or secondary lens subluxation or dislocation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intraocular lens implantation</intervention_name>
    <description>Implantation of an intraocular lens using either an anterior chamber IOL or a scleral fixated IOL using the modified Yamane technique.</description>
    <arm_group_label>Intraocular lens implantation: AC IOL</arm_group_label>
    <arm_group_label>Intraocular lens implantation: SF IOL</arm_group_label>
    <other_name>IOL implantation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who are planned to undergo surgical implantation of an anterior chamber
        intraocular lens or a scleral-fixated IOL who present to the study investigators as part of
        the vitreoretinal surgery team at Sunnybrook Hospital or the Toronto Western Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients who are undergoing AC IOL or SF IOL implantation for any reason (including
             but not limited to aphakia, posterior capsular rupture, primary or secondary lens
             dislocation/ subluxation or IOL exchange).

          2. Patients on whom imaging (specular microscopy, biometry and OCT) can be performed
             without delaying their treatment (i.e. based on availability of operator).

          3. Decision makers able to provide informed consent.

        Exclusion Criteria:

          1. Inability to obtain adequate imaging, in the form of specular microscopy and OCT data
             at baseline.

          2. Patients unable to attend follow-up visits.

          3. Patients who have had a corneal transplant prior to secondary IOL implantation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Kertes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charlene Muller</last_name>
    <phone>416 480 5091</phone>
    <email>charlene.muller@sunnybrook.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sunnybrook Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Charlene Muller</last_name>
      <phone>416 480 5091</phone>
      <email>charlene.muller@sunnybrook.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Chan TC, Lam JK, Jhanji V, Li EY. Comparison of outcomes of primary anterior chamber versus secondary scleral-fixated intraocular lens implantation in complicated cataract surgeries. Am J Ophthalmol. 2015 Feb;159(2):221-6.e2. doi: 10.1016/j.ajo.2014.10.016. Epub 2014 Oct 22.</citation>
    <PMID>25448990</PMID>
  </reference>
  <reference>
    <citation>Krysik K, Dobrowolski D, Wroblewska-Czajka E, Lyssek-Boron A, Wylegala E. Comparison of the Techniques of Secondary Intraocular Lens Implantation after Penetrating Keratoplasty. J Ophthalmol. 2018 Sep 12;2018:3271017. doi: 10.1155/2018/3271017. eCollection 2018.</citation>
    <PMID>30298105</PMID>
  </reference>
  <reference>
    <citation>Kwong YY, Yuen HK, Lam RF, Lee VY, Rao SK, Lam DS. Comparison of outcomes of primary scleral-fixated versus primary anterior chamber intraocular lens implantation in complicated cataract surgeries. Ophthalmology. 2007 Jan;114(1):80-5. Epub 2006 Oct 27.</citation>
    <PMID>17070590</PMID>
  </reference>
  <reference>
    <citation>Negretti GS, Lai M, Petrou P, Walker R, Charteris D. Anterior chamber lens implantation in vitrectomised eyes. Eye (Lond). 2018 Mar;32(3):597-601. doi: 10.1038/eye.2017.261. Epub 2017 Dec 8.</citation>
    <PMID>29219957</PMID>
  </reference>
  <reference>
    <citation>Yamane S, Sato S, Maruyama-Inoue M, Kadonosono K. Flanged Intrascleral Intraocular Lens Fixation with Double-Needle Technique. Ophthalmology. 2017 Aug;124(8):1136-1142. doi: 10.1016/j.ophtha.2017.03.036. Epub 2017 Apr 27.</citation>
    <PMID>28457613</PMID>
  </reference>
  <reference>
    <citation>Brunin G, Sajjad A, Kim EJ, Montes de Oca I, Weikert MP, Wang L, Koch DD, Al-Mohtaseb Z. Secondary intraocular lens implantation: Complication rates, visual acuity, and refractive outcomes. J Cataract Refract Surg. 2017 Mar;43(3):369-376. doi: 10.1016/j.jcrs.2016.12.024.</citation>
    <PMID>28410720</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 26, 2019</study_first_submitted>
  <study_first_submitted_qc>August 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>August 27, 2019</last_update_submitted>
  <last_update_submitted_qc>August 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sunnybrook Health Sciences Centre</investigator_affiliation>
    <investigator_full_name>Dr. Peter Kertes</investigator_full_name>
    <investigator_title>Chief of Ophthalmology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Endothelial Cell Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

